|
|
Volumn 39, Issue 8, 2005, Pages 736-
|
|
Olanzapine-induced gynecomastia [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMIPRAMINE;
OLANZAPINE;
PROLACTIN;
QUETIAPINE;
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
ANAMNESIS;
CASE REPORT;
CLINICAL FEATURE;
CORRELATION ANALYSIS;
DOSE RESPONSE;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
GYNECOMASTIA;
HUMAN;
HYPERPROLACTINEMIA;
LETTER;
MAINTENANCE THERAPY;
MALE;
MONOTHERAPY;
PROLACTIN BLOOD LEVEL;
SCHIZOAFFECTIVE PSYCHOSIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CAPGRAS SYNDROME;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
HALLUCINATION;
PSYCHOLOGICAL ASPECT;
SUICIDE ATTEMPT;
ADULT;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CAPGRAS SYNDROME;
DRUG THERAPY, COMBINATION;
GYNECOMASTIA;
HALLUCINATIONS;
HUMANS;
IMIPRAMINE;
MALE;
SUICIDE, ATTEMPTED;
|
|
EID: 27444442517
PISSN: 00048674
EISSN: 14401614
Source Type: Journal
DOI: 10.1111/j.1440-1614.2005.01666_1.x Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
